Ioversol

碘佛醇

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameIoversol
Drug Alias NameJoversol碘氟醇碘芬斯醇IoversolumJoversoli +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsContrast agentsMyelodysplastic SyndromesMultiple Myeloma +[5] 
Global Approved IndicationsContrast agents
Approved Indications in ChinaContrast agents
Original Approved Country/TerritoryUnited States
Original Approved Date1988/12/30
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMallinckrodt
China Registration ClassN/A

Develop Information

Active CompaniesLiebel-Flarsheim Company Llc
Inactive CompaniesWashington University School Of Medicine
Active IndicationsContrast agents
Inactive IndicationsMyelodysplastic SyndromesMultiple MyelomaLeukemia, Myeloid, Acute +[4] 

Other Information

ATC CodeV08AB07
Related LinksWikipediaDrugBankKEGG